In the News

Builds on existing relationship, in which PPD has provided expertise in clinical development and laboratory services for Pfizer, including across multiple therapeutic areas.

Moderna is collaborating with PPD to conduct the trials.

PPD contributes a variety of clinical development and laboratory services, including strategic expertise to the study design, patient-enrollment epidemiology modeling and biostatistics.

PPD® Laboratories has developed five new molecular, serology and functional assays designed expressly for COVID-19 vaccine and therapy development programs.

Robert King, Hunter Everton and Philip Bartle discuss how to tackle data reporting challenges while significantly reducing both time and cost.

Panteli Theocharous discusses the three major themes that have emerged in 2020 in response to the sharpened focus on advancing the development of CAR-T therapies.

Brent Denton, John Bak and Jonathon Salsbury discuss how light obscuration testing is the preferred method of sub-visible particle quantification, but is not suitable for every preparation.

PPD is extending its digital clinical trial offering to support its biopharma clients' R&D as life science companies continue to find workarounds on trial delays.

Accelerated Enrollment Solutions has introduced a new program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemic.